Highmark Suit Says UPMC Overbilled $300M For Chemo Drugs
By Matt Fair ( September 3, 2014, 4:28 PM EDT) -- Highmark Inc. accused the University of Pittsburgh Medical Center on Wednesday of systemically overbilling the insurer and its members for chemotherapy drugs and services by more than $300 million over the past four years in violation of a series of contracts between the two entities....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.